Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.61
-0.32 (-3.22%)
At close: Jan 2, 2026, 4:00 PM EST
9.76
+0.15 (1.56%)
After-hours: Jan 2, 2026, 7:41 PM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $701.41 million as of January 2, 2026. Its market cap has increased by 199.51% in one year.
Market Cap
701.41M
Enterprise Value
587.10M
1-Year Change
199.51%
Ranking
Category
Stock Price
$9.61
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $701.41M, an increase of 158.48%. That is a compound annual growth rate of 54.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 701.41M | -3.22% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |